HIF1A and cancer: Collectively, our findings identified the Rap druggable biomarkers of mTORC1/HIF-1α signalers and MCT4 lactate exporter as the most plausible anti-cancer therapeutic targets for reversing nutritional FD-potentiated lactate disorders and LCS metastases.